Indicated for the treatment of: 🫁 Non-Small Cell Lung Cancer (NSCLC): Advanced or metastatic stage. 🧬 Requirement: Tumors must be confirmed as ALK-positive or ROS1-positive via an FDA-approved test. It is not effective for patients without these specific mutations.

Dosage and administration

Packaging: 30 Capsules (250 mg each). ⚠️ DOSAGE & ADMINISTRATION: 💊 Standard Dose: 250 mg taken orally twice daily (BID). 🍽 Intake: Swallow capsules whole. Can be taken with or without food. Do not crush or chew. Grapefruit and grapefruit juice should be avoided during treatment as they increase drug levels in the blood.

Pregnancy (can cause fetal harm) and breastfeeding. Congenital Long QT Syndrome. Severe renal or hepatic impairment. Hypersensitivity to Crizotinib.

Common side effects to be aware of: 👀 Visual Disturbances: Trails of light, flashes, or blurred vision (very common, usually mild). 🤢 Gastrointestinal: Nausea, diarrhea, vomiting, constipation. ❤️ Cardiac: Bradycardia (slow heart rate), QT prolongation. Edema (swelling) and elevated liver enzymes.

Crikzo — Crizotinib 250 mg, 30 pcs, Hetero

100% original product

Active ingredient

Crizotinib

Manufacturer

Hetero

Dosage 250 mg

Dosage form Capsules

Capsules per pack 30

Crikzo (Crizotinib) 250 mg

Name: Crikzo
Brand: Hetero
SKU: PROD-111
Price: 19118 UAH
Availability: InStock

19118₴ ~~21052₴~~ -9%

Crikzo (Crizotinib 250 mg) is an oral targeted therapy known as a Tyrosine Kinase Inhibitor (TKI).

Manufacturer: Hetero Healthcare (India). It is a generic version of Xalkori. Instead of killing all rapidly dividing cells like chemotherapy, Crikzo specifically targets cancer cells that harbor specific genetic mutations.

Mechanism of Action ("Signal Blocker"):

Crizotinib works by inhibiting the ALK (Anaplastic Lymphoma Kinase) or ROS1 proteins. In patients with these specific gene mutations, the protein acts like a stuck gas pedal, driving cancer growth. Crikzo blocks this protein, effectively taking the foot off the gas pedal, causing the tumor to stop growing or shrink.

✅ Key Benefit: Significant improvement in progression-free survival for patients with specific genetic biomarkers.

Indicated for the treatment of:

🫁 Non-Small Cell Lung Cancer (NSCLC): Advanced or metastatic stage.
🧬 Requirement: Tumors must be confirmed as ALK-positive or ROS1-positive via an FDA-approved test.
It is not effective for patients without these specific mutations.

Packaging: 30 Capsules (250 mg each).

⚠️ DOSAGE & ADMINISTRATION:

💊 Standard Dose: 250 mg taken orally twice daily (BID).
🍽 Intake: Swallow capsules whole. Can be taken with or without food. Do not crush or chew.
Grapefruit and grapefruit juice should be avoided during treatment as they increase drug levels in the blood.

Pregnancy (can cause fetal harm) and breastfeeding.
Congenital Long QT Syndrome.
Severe renal or hepatic impairment.
Hypersensitivity to Crizotinib.

Common side effects to be aware of:

👀 Visual Disturbances: Trails of light, flashes, or blurred vision (very common, usually mild).
🤢 Gastrointestinal: Nausea, diarrhea, vomiting, constipation.
❤️ Cardiac: Bradycardia (slow heart rate), QT prolongation.
Edema (swelling) and elevated liver enzymes.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 07.03.2026